Rankings
▼
Calendar
JAZZ FY 2008 Earnings — Jazz Pharmaceuticals plc Revenue & Financial Results | Market Cap Arena
JAZZ
Jazz Pharmaceuticals plc
$11B
FY 2008 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$68M
+3.4% YoY
Gross Profit
$54M
79.4% margin
Operating Income
-$170M
-252.3% margin
Net Income
-$184M
-273.0% margin
EPS (Diluted)
$-7.19
Cash Flow
Operating Cash Flow
-$130M
Free Cash Flow
-$159M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$117M
Total Liabilities
$210M
Stockholders' Equity
-$93M
Cash & Equivalents
$25M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$68M
$65M
+3.4%
Gross Profit
$54M
$56M
-5.0%
Operating Income
-$170M
-$139M
-22.8%
Net Income
-$184M
-$139M
-32.8%
← FY 2007
All Quarters
FY 2009 →